Atherogenic index of plasma is an independent predictor of mitral annular calcification

Sezen Baglan Uzunget1, Kader Eliz Sahin2

  • 1Department of Cardiology, Sincan State Hospital Ankara, Ankara, Turkey. sezenbaglan@hotmail.com.

Insights

Atherogenic Index of Plasma (AIP) is linked to mitral annular calcification (MAC). Higher AIP independently predicts the presence of MAC, suggesting a potential new marker for cardiac health.

Area of Science:

  • Cardiology
  • Biochemistry
  • Medical Diagnostics

Background:

  • Atherogenic indices are linked to various cardiac conditions.
  • Conventional risk factors are associated with mitral annular calcification (MAC).
  • Data on atherogenic indices and MAC are limited.

Purpose of the Study:

  • To investigate the relationship between MAC and atherogenic indices.
  • To determine if atherogenic indices can predict MAC.

Main Methods:

  • 741 patients (427 with MAC, 314 without) were studied.
  • MAC diagnosed via transthoracic echocardiography.
  • Atherogenic coefficient (AC), Castelli risk indices (CRI-1, CRI-2), and Atherogenic Index of Plasma (AIP) calculated from lipid profiles.

Main Results:

  • No significant differences in sex, age, diabetes, or hypertension between groups.
  • Serum triglyceride, AIP, Hs-CRP, smoking, and BMI were independently associated with MAC (p < 0.001).

Conclusions:

  • Higher AIP is related to the presence of MAC.
  • AIP independently predicts MAC.
  • Further studies on modifying these indices are warranted.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
56
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
29
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
25
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
18